Loading...
Header Logo
Keywords
Last Name
Institution

Mustafa Ata Atik

TitleInstructor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
DivisionMedicine-Pulmonary
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Parulekar AD, Martinez C, Tsai CL, Locantore N, Atik M, Yohannes AM, Kao CC, Al-Azzawi H, Mohsin A, Wise RA, Foreman MG, Demeo DL, Regan EA, Make BJ, Boriek AM, Wiener LE, Hanania NA. Examining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts. J Am Med Dir Assoc. 2017 Dec 01; 18(12):1063-1068. PMID: 29169736.
      View in: PubMed
    2. Tanner MR, Tajhya RB, Huq R, Gehrmann EJ, Rodarte KE, Atik MA, Norton RS, Pennington MW, Beeton C. Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog. Clin Immunol. 2017 07; 180:45-57. PMID: 28389388.
      View in: PubMed
    3. Koshy S, Huq R, Tanner MR, Atik MA, Porter PC, Khan FS, Pennington MW, Hanania NA, Corry DB, Beeton C. Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma. J Biol Chem. 2014 May 02; 289(18):12623-32. PMID: 24644290.
      View in: PubMed
    4. Parulekar AD, Atik MA, Hanania NA. Periostin, a novel biomarker of TH2-driven asthma. Curr Opin Pulm Med. 2014 Jan; 20(1):60-5. PMID: 24247042.
      View in: PubMed
    5. Powner DJ, Hergenroeder GW, Awili M, Atik MA, Robertson C. Hyponatremia and comparison of NT-pro-BNP concentrations in blood samples from jugular bulb and arterial sites after traumatic brain injury in adults: a pilot study. Neurocrit Care. 2007; 7(2):119-23. PMID: 17690842.
      View in: PubMed
    6. Atik MA, Ates M, Akkus NI, Altundag O, Altundag K. Preoperative Doppler sonography for prevention of perioperative stroke in head and neck cancer patients undergoing neck dissection: is it beneficial? J Clin Ultrasound. 2007 Jan; 35(1):38-9. PMID: 17131402.
      View in: PubMed
    7. Altundag K, Altundag O, Atik MA, Boruban C, Altundag MB, Turen S. Recent findings for anti-metastatic potential of heparin. Clin Appl Thromb Hemost. 2006 Jul; 12(3):376-7. PMID: 16959695.
      View in: PubMed
    8. Altundag K, Altundag O, Akyurek S, Atik MA. Possible association between nanobacteria and malignant microcalcifications in breast cancer. Breast J. 2006 May-Jun; 12(3):287. PMID: 16684338.
      View in: PubMed
    9. Altundag K, Altundag O, Baptista MZ, Turen S, Atik MA. Re: Cetuximab therapy and symptomatic hypomagnesemia. J Natl Cancer Inst. 2005 Dec 07; 97(23):1791-2. PMID: 16333039.
      View in: PubMed
    10. Altundag K, Altundag O, Baptista MZ, Atik MA. Which is better in neoadjuvant treatment of breast cancer? Taxane followed by anthracyline or vice versa. Breast Cancer Res Treat. 2006 May; 97(2):221. PMID: 16319972.
      View in: PubMed
    11. Altundag K, Altundag O, Baptista MZ, Turen S, Atik MA. Is there an association between high heparanase level and osteoporosis risk in breast cancer patients without clinical evidence of bone metastases? Osteoporos Int. 2005 Dec; 16(12):2195-6. PMID: 16273325.
      View in: PubMed
    12. Altundag O, Ates M, Atik MA, Altundag K. Adjuvant chemotherapy in patients 80-89 years of age with non-small cell lung cancer. Eur J Cardiothorac Surg. 2005 Dec; 28(6):911-2; author reply 912. PMID: 16242942.
      View in: PubMed
    13. Altundag K, Altundag O, Gundeslioglu O, Turen S, Islam R, Atik MA. Low incidence of mamographically detected microcalcification in breast cancer patients with lobular histology may be attributed to low levels of osteopontin. Med Hypotheses. 2006; 67(2):421-2. PMID: 16219427.
      View in: PubMed
    14. Altundag K, Altundag O, Atik MA, Morandi P, Gunduz M. Rationale for the use of trastuzumab in patients with cerebral metastases who previously receive trastuzumab-based therapy for metastatic breast cancer. Breast. 2005 Oct; 14(5):425. PMID: 16216749.
      View in: PubMed
    15. Altundag K, Altundag O, Atik MA. Heparin and CXCL12 dimerization. J Clin Oncol. 2005 Oct 01; 23(28):7248. PMID: 16192624.
      View in: PubMed
    16. Altundag K, Silay YS, Altundag O, Atik MA, Aktolga S. Bisphosphonate use for osteoporosis in postmenopausal women may inhibit occurrence of malignant microcalcification in breast tissue. Med Hypotheses. 2006; 67(1):202-3. PMID: 16165306.
      View in: PubMed
    17. Altundag O, Altundag K, Turen S, Gunduz E, Atik MA. Aromatase inhibitors may be effective in the management of advanced hepatocellular carcinoma. Med Hypotheses. 2006; 66(6):1257. PMID: 16154711.
      View in: PubMed
    18. Silay YS, Altundag K, Altundag O, Atik MA, Ozen M. Bisphosphonates may inhibit development of atherosclerosis formation through its bactericidal effect on nanobacteria. Med Hypotheses. 2005; 64(6):1239-40. PMID: 15823727.
      View in: PubMed
    Atik's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description